The PET result was strongly correlated with survival, confirming the potential of PSMA-targeted PET as an aggressiveness biomarker (Figure 8a), while the expression of PSMA in tissue specimens could not discriminate towards aggressive phenotypes of RCC (Figure 10a,b). Here, FOLH1 is linked to renal cell carcinoma.